Westfield Capital Management CO LP Ironwood Pharmaceuticals Inc Transaction History

Westfield Capital Management CO LP

$21.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.9 - $12.43 $6.72 Million - $8.44 Million	-679,278 Reduced 72.82%	253,491 $3.14 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $14 Million - $17.1 Million	-1,383,359 Reduced 59.73%	932,769 $9.66 Million
Q2 2022 Aug 12, 2022	SELL	$11.05 - $12.72 $68.7 Million - $79.1 Million	-6,218,288 Reduced 72.86%	2,316,128 $26.7 Million
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $4.12 Million - $5.01 Million	388,742 Added 4.77%	8,534,416 $107 Million
Q4 2021 Feb 10, 2022	SELL	$10.86 - $13.95 $383,672 - $492,839	-35,329 Reduced 0.43%	8,145,674 $95 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $22.9 Million - $26.8 Million	1,922,130 Added 30.71%	8,181,003 $107 Million
Q2 2021 Aug 10, 2021	BUY	$10.16 - $13.11 $8.89 Million - $11.5 Million	875,223 Added 16.26%	6,258,873 $80.6 Million
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $28.1 Million - $36.8 Million	-3,104,392 Reduced 36.57%	5,383,650 $60.2 Million
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $14.9 Million - $20 Million	1,641,850 Added 23.98%	8,488,042 $96.7 Million
Q3 2020 Nov 13, 2020	BUY	$8.99 - $10.74 $13.5 Million - $16.2 Million	1,504,988 Added 28.18%	6,846,192 $61.6 Million
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $5.08 Million - $6.66 Million	556,078 Added 11.62%	5,341,204 $55.1 Million
Q1 2020 May 14, 2020	BUY	$8.58 - $14.01 $20.1 Million - $32.9 Million	2,348,030 Added 96.35%	4,785,126 $48.3 Million
Q4 2019 Feb 13, 2020	SELL	$8.22 - $14.0 $701,930 - $1.2 Million	-85,393 Reduced 3.39%	2,437,096 $32.4 Million
Q3 2019 Nov 08, 2019	BUY	$8.59 - $10.96 $1.11 Million - $1.42 Million	129,715 Added 5.42%	2,522,489 $21.7 Million
Q2 2019 Aug 13, 2019	BUY	$9.8 - $12.89 $5.01 Million - $6.59 Million	510,900 Added 27.15%	2,392,774 $26.2 Million
Q1 2019 May 14, 2019	SELL	$8.27 - $12.73 $769,151 - $1.18 Million	-93,005 Reduced 4.71%	1,881,874 $25.5 Million
Q4 2018 Feb 08, 2019	BUY	$7.8 - $16.13 $749,346 - $1.55 Million	96,070 Added 5.11%	1,974,879 $20.5 Million
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $6.96 Million - $8.59 Million	486,578 Added 34.95%	1,878,809 $34.7 Million
Q2 2018 Aug 13, 2018	BUY	$11.83 - $16.2 $16.5 Million - $22.6 Million	1,392,231 New	1,392,231 $26.6 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.6 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.7 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.7 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$34.9 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account